Alberta Investment Management Corp (AIMCo)’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
– Sell
-19,335
Closed -$280K – 1294
2022
Q2
$280K Buy
+19,335
New +$330K ﹤0.01% 1131

Other funds holding HCAT

Alberta Investment Management Corp (AIMCo)'s HCAT Position: Q3 2022 in Review

Alberta Investment Management Corp (AIMCo) sold out of Health Catalyst (HCAT) in Q3 2022, closing a stake of 19,335 shares — an estimated $280K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in HCAT in Q2 2022 and held it in 1 quarter. The position peaked at $280K in Q2 2022. 171 funds tracked by Wall St. Rank hold HCAT as of Q3 2022.

  • Alberta Investment Management Corp (AIMCo) reported no remaining Health Catalyst position as of Q3 2022 after selling out during the quarter.
  • Alberta Investment Management Corp (AIMCo) sold 19,335 Health Catalyst shares in Q3 2022, an estimated $280K.
  • Alberta Investment Management Corp (AIMCo) first reported a position in Health Catalyst in Q2 2022 and held it in 1 quarter.
  • Alberta Investment Management Corp (AIMCo)'s Health Catalyst position peaked at $280K in Q2 2022.
  • 171 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2022.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2022, filed 14 Nov 2022.